{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:48:26Z","timestamp":1791938906825,"version":"4.3.4"},"reference-count":183,"publisher":"American Society for Microbiology","issue":"4","license":[{"start":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T00:00:00Z","timestamp":1765411200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1128\/ASMCopyrightv2"},{"start":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T00:00:00Z","timestamp":1765411200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"DOI":"10.13039\/100004423","name":"World Health Organization","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004423","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Clin Microbiol Rev"],"published-print":{"date-parts":[[2025,12,11]]},"abstract":"<jats:title>SUMMARY<\/jats:title>\n                  <jats:p>Drug-resistant tuberculosis (DR-TB) causes substantial morbidity and mortality and has hindered progress toward TB elimination. This slowed progress toward the WHO End TB Strategy\u2019s targets was exacerbated by lower TB detection during the COVID-19 pandemic. To inform research and development priorities, we conducted a narrative review of global DR-TB epidemiology and strategies for DR-TB prevention, diagnostics, and treatment. Gaps remain in DR-TB diagnosis, TB drug susceptibility testing (DST), and treatment. The review also shows that DR-TB causes significant post-disease disability, particularly chronic lung disease, impacting quality of life. Newer oral regimens for multidrug-resistant TB are shorter and more effective than traditional regimens. New antibiotics under development may help overcome remaining safety and tolerability issues, while novel advanced therapeutics and precision medicine offer hope to those failing treatment. Emerging diagnostics include rapid DST for second-line drugs, but a paradigm shift is needed to ensure novel DSTs become available as new drugs are introduced. Person-centered research is urgently needed to accelerate the response to DR-TB amidst the global threat of antimicrobial resistance, yet global investment in TB prevention and care currently falls short of need. A holistic approach to interventions to improve DR-TB prevention and care is needed, encompassing all health system components and their interactions, including a One Health approach and consideration of the wider determinants of health.<\/jats:p>","DOI":"10.1128\/cmr.00064-25","type":"journal-article","created":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T14:00:11Z","timestamp":1762264811000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":6,"title":["Drug-resistant tuberculosis: a priority pathogen for enhanced public health research and practice"],"prefix":"10.1128","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0100-4754","authenticated-orcid":true,"given":"H. Manisha","family":"Yapa","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/0384j8v12","id-type":"ROR","asserted-by":"publisher"}],"name":"Faculty of Medicine and Health, The University of Sydney","place":["Sydney, Australia"]},{"name":"Sydney Infectious Diseases Institute, University of Sydney","place":["Sydney, Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9272-0985","authenticated-orcid":true,"given":"Emily L.-H.","family":"MacLean","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/0384j8v12","id-type":"ROR","asserted-by":"publisher"}],"name":"Faculty of Medicine and Health, The University of Sydney","place":["Sydney, Australia"]},{"name":"Sydney Infectious Diseases Institute, University of Sydney","place":["Sydney, Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas A.","family":"Menzies","sequence":"additional","affiliation":[{"name":"Harvard T.H. Chan School of Public Health","place":["Boston, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Dodd","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05krs5044","id-type":"ROR","asserted-by":"publisher"}],"name":"Sheffield Centre for Health and Related Research, University of Sheffield","place":["Sheffield, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Dean","sequence":"additional","affiliation":[{"name":"WHO Global Tuberculosis Program, World Health Organization","place":["Geneva, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuad","family":"Mirzayev","sequence":"additional","affiliation":[{"name":"WHO Global Tuberculosis Program, World Health Organization","place":["Geneva, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel G.","family":"Schumacher","sequence":"additional","affiliation":[{"name":"WHO Global Tuberculosis Program, World Health Organization","place":["Geneva, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linh N.","family":"Nguyen","sequence":"additional","affiliation":[{"name":"WHO Global Tuberculosis Program, World Health Organization","place":["Geneva, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Zignol","sequence":"additional","affiliation":[{"name":"WHO Global Tuberculosis Program, World Health Organization","place":["Geneva, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greg J.","family":"Fox","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/0384j8v12","id-type":"ROR","asserted-by":"publisher"}],"name":"Faculty of Medicine and Health, The University of Sydney","place":["Sydney, Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_3_2_2","unstructured":"WHO. 2023. Antimicrobial resistance. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/antimicrobial-resistance. Retrieved 23 Feb 2025."},{"key":"e_1_3_3_3_2","unstructured":"WHO. 2024. Global tuberculosis report 2024. Geneva: World Health Organization"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2022.03.026"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-022-00731-y"},{"key":"e_1_3_3_6_2","unstructured":"WHO. 2023. Tackling the drug-resistant TB crisis. Available from: https:\/\/www.who.int\/activities\/tackling-the-drug-resistant-tb-crisis#:~:text=Drug%2Dresistant%20tuberculosis%20(TB) with%20drug%2Dresistant%20TB%20globally. Retrieved 5 May 2023."},{"key":"e_1_3_3_7_2","unstructured":"WHO. 2024. The top 10 causes of death. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/the-top-10-causes-of-death. Retrieved 15 Dec 2024."},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1590\/1806-3713\/e20180324"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(21)00367-3"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1159\/000512531"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-41937-9"},{"key":"e_1_3_3_12_2","unstructured":"World Health Organization. 2021. WHO global lists of high burden countries for tuberculosis (TB) TB\/HIV and multidrug\/rifampicin-resistant TB (MDR\/RR-TB) 2021\u20132025. Available from: https:\/\/cdn.who.int\/media\/docs\/default-source\/hq-tuberculosis\/who_globalhbcliststb_2021-2025_backgrounddocument.pdf?sfvrsn=f6b854c2_9. Retrieved 2 Dec 2022."},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003008"},{"key":"e_1_3_3_14_2","volume-title":"The end TB strategy","author":"WHO","year":"2015","unstructured":"WHO. 2015. The end TB strategy. World Health Organization, Geneva."},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(19)30420-7"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(22)00092-3"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)30024-8"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)01379-X"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268818001760"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-024-01025-1"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(17)30079-6"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1128\/cmr.00180-19"},{"key":"e_1_3_3_23_2","volume-title":"Bacterial priority pathogens list","author":"WHO","year":"2024","unstructured":"WHO. 2024. Annex 4: Independent analyses of Mycobacterium tuberculosis, rifampicin-resistant. In Bacterial priority pathogens list. World Health Organization, Geneva."},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201305-0926OE"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2023.04.392"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201909-1819LE"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201902-0260LE"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz074"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1815121"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2666-5247(23)00172-6"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(23)00498-X"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00915-19"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41390-025-03917-1"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-025-04269-7"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(21)00808-2"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-021-02063-9"},{"key":"e_1_3_3_37_2","volume-title":"WHO consolidated guidelines on tuberculosis: Module 4: treatment - drug-resistant tuberculosis treatment, 2022 update","author":"WHO","year":"2022","unstructured":"WHO. 2022. WHO consolidated guidelines on tuberculosis: Module 4: treatment - drug-resistant tuberculosis treatment, 2022 update. World Health Organization, Geneva."},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00022912"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciad653"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2018-000745"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00042-10"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2004.00758.x"},{"key":"e_1_3_3_43_2","first-page":"2985","volume-title":"Mandell, Douglas, and Bennett\u2019s Principles and Practice of Infectious Diseases","author":"Fitzgerald DW","year":"2020","unstructured":"Fitzgerald DW, Sterling TR, Haas D. 2020. Mycobacterium tuberculosis, p 2985\u20133021. In Mandell, Douglas, and Bennett\u2019s Principles and Practice of Infectious Diseases, 9th ed. Elsevier, Philadelphia.","edition":"9"},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2024.07.011"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-032712-095939"},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2016.76"},{"key":"e_1_3_3_47_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202110-2378OC"},{"key":"e_1_3_3_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(15)00499-5"},{"key":"e_1_3_3_49_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a118097"},{"key":"e_1_3_3_50_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.43.8.1866"},{"key":"e_1_3_3_51_2","doi-asserted-by":"publisher","DOI":"10.1086\/379895"},{"key":"e_1_3_3_52_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro2319"},{"key":"e_1_3_3_53_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1124410"},{"key":"e_1_3_3_54_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.0020061"},{"key":"e_1_3_3_55_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tube.2021.102091"},{"key":"e_1_3_3_56_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-37719-y"},{"key":"e_1_3_3_57_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2878"},{"key":"e_1_3_3_58_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiv347"},{"key":"e_1_3_3_59_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2008.02685.x"},{"key":"e_1_3_3_60_2","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01044-2017"},{"key":"e_1_3_3_61_2","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00071212"},{"key":"e_1_3_3_62_2","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.10.0781"},{"key":"e_1_3_3_63_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid1606.091844"},{"key":"e_1_3_3_64_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid1507.080994"},{"key":"e_1_3_3_65_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(15)00458-0"},{"key":"e_1_3_3_66_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(16)30418-2"},{"key":"e_1_3_3_67_2","doi-asserted-by":"publisher","DOI":"10.1086\/592991"},{"key":"e_1_3_3_68_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1604544"},{"key":"e_1_3_3_69_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)60598-4"},{"key":"e_1_3_3_70_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(24)00059-8"},{"key":"e_1_3_3_71_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2666-5247(20)30142-7"},{"key":"e_1_3_3_72_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.43.7.3530-3532.2005"},{"key":"e_1_3_3_73_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1503141112"},{"key":"e_1_3_3_74_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00002-11"},{"key":"e_1_3_3_75_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofae733"},{"key":"e_1_3_3_76_2","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens14070684"},{"key":"e_1_3_3_77_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2010.11.008"},{"key":"e_1_3_3_78_2","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.01586-16"},{"key":"e_1_3_3_79_2","volume-title":"WHO guidelines on tuberculosis infection prevention and control, 2019 update","author":"WHO","year":"2019","unstructured":"WHO. 2019. WHO guidelines on tuberculosis infection prevention and control, 2019 update. World Health Organization, Geneva."},{"key":"e_1_3_3_80_2","volume-title":"WHO consolidated guidelines on tuberculosis. Module 2: Screening. Systematic screening for tuberculosis disease","author":"WHO","year":"2021","unstructured":"WHO. 2021. WHO consolidated guidelines on tuberculosis. Module 2: Screening. Systematic screening for tuberculosis disease. World Health Organization, Geneva."},{"key":"e_1_3_3_81_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa719"},{"key":"e_1_3_3_82_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-2667(21)00033-5"},{"key":"e_1_3_3_83_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1902129"},{"key":"e_1_3_3_84_2","volume-title":"Latent tuberculosis infection: updated and consolidated guidelines for programmatic management","author":"WHO","year":"2018","unstructured":"WHO. 2018. Latent tuberculosis infection: updated and consolidated guidelines for programmatic management. World Health Organization, Geneva."},{"key":"e_1_3_3_85_2","volume-title":"WHO consolidated guidelines on tuberculosis. Module 1: Prevention. Tuberculosis preventive treatment","author":"WHO","year":"2020","unstructured":"WHO. 2020. WHO consolidated guidelines on tuberculosis. Module 1: Prevention. Tuberculosis preventive treatment. World Health Organization, Geneva."},{"key":"e_1_3_3_86_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2314325"},{"key":"e_1_3_3_87_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2314318"},{"key":"e_1_3_3_88_2","unstructured":"Churchyard G Gupta A Hesseling A Swindells S. 2019. Protecting households on exposure to newly diagnosed index multidrug-resistant tuberculosis patients (PHOENIx MDR-TB). Available from: https:\/\/clinicaltrials.gov\/study\/NCT03568383. Retrieved 23 Feb 2025."},{"key":"e_1_3_3_89_2","volume-title":"An investment case for new tuberculosis vaccines","author":"WHO","year":"2022","unstructured":"WHO. 2022. An investment case for new tuberculosis vaccines. World Health Organization, Geneva."},{"key":"e_1_3_3_90_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(22)00283-2"},{"key":"e_1_3_3_91_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaf1098"},{"key":"e_1_3_3_92_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(23)00045-1"},{"key":"e_1_3_3_93_2","unstructured":"Working Group on New Vaccines. 2024. TB vaccine clinical pipeline. Available from: https:\/\/newtbvaccines.org\/tb-vaccine-pipeline\/. Retrieved 23 Feb 2025."},{"key":"e_1_3_3_94_2","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1909953"},{"key":"e_1_3_3_95_2","volume-title":"WHO operational handbook on tuberculosis. Module 3: diagnosis - rapid diagnostics for tuberculosis detection","author":"WHO","year":"2024","unstructured":"WHO. 2024. WHO operational handbook on tuberculosis. Module 3: diagnosis - rapid diagnostics for tuberculosis detection. World Health Organization, Geneva."},{"key":"e_1_3_3_96_2","doi-asserted-by":"publisher","DOI":"10.9745\/GHSP-D-21-00121"},{"key":"e_1_3_3_97_2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD014841.pub2"},{"key":"e_1_3_3_98_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2016.10.014"},{"key":"e_1_3_3_99_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2666-5247(21)00301-3"},{"key":"e_1_3_3_100_2","volume-title":"The use of next-generation sequencing technologies for the detection of mutations associated with drug resistance in Mycobacterium tuberculosis complex: technical guide","author":"WHO","year":"2018","unstructured":"WHO. 2018. The use of next-generation sequencing technologies for the detection of mutations associated with drug resistance in Mycobacterium tuberculosis complex: technical guide. World Health Organization, Geneva."},{"key":"e_1_3_3_101_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-022-01054-6"},{"key":"e_1_3_3_102_2","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02338-2020"},{"key":"e_1_3_3_103_2","volume-title":"Target regimen profiles for tuberculosis treatment, 2023 update","author":"WHO","year":"2023","unstructured":"WHO. 2023. Target regimen profiles for tuberculosis treatment, 2023 update. World Health Organization, Geneva."},{"key":"e_1_3_3_104_2","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2023.2178243"},{"key":"e_1_3_3_105_2","unstructured":"WHO. 2024. Global tuberculosis report 2024. Chapter 6\u2014TB research & innovation. Geneva: World Health Organization"},{"key":"e_1_3_3_106_2","unstructured":"Vachaspathi TD. 2024. Pipeline report 2024: tuberculosis diagnostics. Available from: https:\/\/www.treatmentactiongroup.org\/wp-content\/uploads\/2025\/02\/2024_pipeline_tb_diagnostics_final.pdf. Retrieved 31 Aug 2025."},{"key":"e_1_3_3_107_2","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.00860-22"},{"key":"e_1_3_3_108_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(19)30707-8"},{"key":"e_1_3_3_109_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.00421-22"},{"key":"e_1_3_3_110_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12941-023-00633-8"},{"key":"e_1_3_3_111_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiae282"},{"key":"e_1_3_3_112_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(23)00469-2"},{"key":"e_1_3_3_113_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jctube.2024.100444"},{"key":"e_1_3_3_114_2","doi-asserted-by":"publisher","DOI":"10.2147\/PGPM.S15454"},{"key":"e_1_3_3_115_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiac024"},{"key":"e_1_3_3_116_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.111631"},{"key":"e_1_3_3_117_2","unstructured":"World Health Organization. 2022. The WHO consolidated guidelines on tuberculosis module 4: treatment-drug-resistant tuberculosis treatment 2022 update"},{"key":"e_1_3_3_118_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2119430"},{"key":"e_1_3_3_119_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2117166"},{"key":"e_1_3_3_120_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2400327"},{"key":"e_1_3_3_121_2","doi-asserted-by":"publisher","DOI":"10.1111\/cbdd.12549"},{"key":"e_1_3_3_122_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00021-12"},{"key":"e_1_3_3_123_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3937"},{"key":"e_1_3_3_124_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tube.2010.07.002"},{"key":"e_1_3_3_125_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201711-2333OC"},{"key":"e_1_3_3_126_2","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a017863"},{"key":"e_1_3_3_127_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00913-19"},{"key":"e_1_3_3_128_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkac067"},{"key":"e_1_3_3_129_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ921"},{"key":"e_1_3_3_130_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02784-14"},{"key":"e_1_3_3_131_2","doi-asserted-by":"publisher","DOI":"10.2471\/BLT.17.193375"},{"key":"e_1_3_3_132_2","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01467-2019"},{"key":"e_1_3_3_133_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01442-2"},{"key":"e_1_3_3_134_2","doi-asserted-by":"publisher","DOI":"10.4103\/2229-516X.112228"},{"key":"e_1_3_3_135_2","unstructured":"FDA News Release. 2019. FDA approves new drug for treatment-resistant forms of tuberculosis that affects the lungs. US Food & Drug Administration."},{"key":"e_1_3_3_136_2","unstructured":"Working Group on New TB Drugs. 2025. Clinical pipeline. Available from: https:\/\/www.newtbdrugs.org\/pipeline\/clinical. Retrieved 28 Jul 2025."},{"key":"e_1_3_3_137_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.trsl.2020.03.007"},{"key":"e_1_3_3_138_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-024-07912-5"},{"key":"e_1_3_3_139_2","unstructured":"Hoelscher M. 2022. BTZ-043 - Multiple ascending dose (MAD) to evaluate safety tolerability and early bactericidal activity (EBA). Available from: https:\/\/clinicaltrials.gov\/study\/NCT04044001. Retrieved 28 Jul 2025."},{"key":"e_1_3_3_140_2","unstructured":"MSF. 2021. Lifesaving TB medicines still out of reach for children in high-burden countries. Medicins Sans Frontieres."},{"key":"e_1_3_3_141_2","doi-asserted-by":"publisher","DOI":"10.3390\/v10040205"},{"key":"e_1_3_3_142_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-019-0634-z"},{"key":"e_1_3_3_143_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciac453"},{"key":"e_1_3_3_144_2","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00973-21"},{"key":"e_1_3_3_145_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaa389"},{"key":"e_1_3_3_146_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02071-21"},{"key":"e_1_3_3_147_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.abq6990"},{"key":"e_1_3_3_148_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-023-06243-w"},{"key":"e_1_3_3_149_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20230903"},{"key":"e_1_3_3_150_2","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1147454"},{"key":"e_1_3_3_151_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofae133"},{"key":"e_1_3_3_152_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ615"},{"key":"e_1_3_3_153_2","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abh1209"},{"key":"e_1_3_3_154_2","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.03413-23"},{"key":"e_1_3_3_155_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-14-2920"},{"key":"e_1_3_3_156_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.021908.132703"},{"key":"e_1_3_3_157_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(20)30448-3"},{"key":"e_1_3_3_158_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-4-44"},{"key":"e_1_3_3_159_2","doi-asserted-by":"publisher","DOI":"10.4046\/trd.2004.57.3.226"},{"key":"e_1_3_3_160_2","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2004.19.2.167"},{"key":"e_1_3_3_161_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(23)00067-1"},{"key":"e_1_3_3_162_2","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02512-2021"},{"key":"e_1_3_3_163_2","doi-asserted-by":"publisher","DOI":"10.1002\/jin2.61"},{"key":"e_1_3_3_164_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-023-02156-y"},{"key":"e_1_3_3_165_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cej.2017.12.110"},{"key":"e_1_3_3_166_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30792-1"},{"key":"e_1_3_3_167_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-020-05575-6"},{"key":"e_1_3_3_168_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0050152"},{"key":"e_1_3_3_169_2","volume-title":"Western Pacific regional framework to end TB: 2021-2030: brief summary","author":"WHO","year":"2022","unstructured":"WHO. 2022. Western Pacific regional framework to end TB: 2021-2030: brief summary. World Health Organization, Manila."},{"key":"e_1_3_3_170_2","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2010.199505"},{"key":"e_1_3_3_171_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(16)30139-6"},{"key":"e_1_3_3_172_2","volume-title":"Guidelines for the control of Mycobacterium tuberculosis complex in livestock: beyond test and slaughter","author":"WOAH","year":"2024","unstructured":"WOAH. 2024. Guidelines for the control of Mycobacterium tuberculosis complex in livestock: beyond test and slaughter. World Organisation for Animal Health, Paris."},{"key":"e_1_3_3_173_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30166-3"},{"key":"e_1_3_3_174_2","volume-title":"Systems thinking for health systems strengthening","author":"WHO","year":"2009","unstructured":"WHO. 2009. Systems thinking for health systems strengthening. Alliance for Health Policy and Systems Research, World Health Organization, Geneva."},{"key":"e_1_3_3_175_2","volume-title":"Health systems and the challenge of communicable disease","author":"Atun R","year":"2008","unstructured":"Atun R, Menabde N. 2008. Health systems and systems thinking. In Coker R, Atun R, McKee M (ed), Health systems and the challenge of communicable disease. Open University Press, New York."},{"key":"e_1_3_3_176_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f6753"},{"key":"e_1_3_3_177_2","volume-title":"When do vertical (stand-alone) programmes have a place in health systems?","author":"Atun RA","year":"2008","unstructured":"Atun RA, Bennett S, Duran A. 2008. When do vertical (stand-alone) programmes have a place in health systems? World Health Organization, Denmark."},{"key":"e_1_3_3_178_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)30602-5"},{"key":"e_1_3_3_179_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2017.02.020"},{"key":"e_1_3_3_180_2","first-page":"5782","article-title":"The Gambia Hepatitis Intervention Study","volume":"47","author":"The Gambia Hepatitis Study Group","year":"1987","unstructured":"The Gambia Hepatitis Study Group. 1987. The Gambia Hepatitis Intervention Study. Cancer Res 47:5782\u20135787.","journal-title":"Cancer Res"},{"key":"e_1_3_3_181_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13012-018-0847-1"},{"key":"e_1_3_3_182_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h1258"},{"key":"e_1_3_3_183_2","unstructured":"Stop TB Partnership. 2022. Worldwide TB R&D funding surpasses US$1 billion but falls short of goals. Available from: https:\/\/www.stoptb.org\/news\/worldwide-tb-rd-funding-surpasses-us1-billion-falls-short-of-goals. Retrieved 11 Feb 2023."},{"key":"e_1_3_3_184_2","volume-title":"Evidence and research gaps identified during development of policy guidelines for tuberculosis","author":"WHO","year":"2023","unstructured":"WHO. 2023. Evidence and research gaps identified during development of policy guidelines for tuberculosis. Second edition. World Health Organization, Geneva."}],"container-title":["Clinical Microbiology Reviews"],"original-title":[],"contributor":[{"given":"Lina","family":"Davies Forsman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"reviewer"}]},{"given":"Chao","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"reviewer"}]}],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/cmr.00064-25","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/cmr.00064-25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T14:02:10Z","timestamp":1765461730000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/cmr.00064-25"}},"subtitle":[],"editor":[{"given":"Graeme N.","family":"Forrest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,12,11]]},"references-count":183,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,12,11]]}},"alternative-id":["10.1128\/cmr.00064-25"],"URL":"https:\/\/doi.org\/10.1128\/cmr.00064-25","relation":{},"ISSN":["0893-8512","1098-6618"],"issn-type":[{"value":"0893-8512","type":"print"},{"value":"1098-6618","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,11]]},"assertion":[{"value":"2025-11-04","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e00064-25"}}